US STOCKS-Wall St rebounds with financials; biotechs drop
* Biotechs sell off after Clinton tweet
* Biogen, Gilead among biggest drags
* Dow up 0.8 pct, S&P up 0.5 pct, Nasdaq down 0.04 pct (Updates to close)
By Caroline Valetkevitch
Sept 21 (Reuters) - U.S. stocks ended higher on Monday, rebounding from losses late last week with help from Apple and financial shares, but a drop in biotech shares limited the advance.
Shares of biotech companies fell after U.S. Democratic presidential candidate Hillary Clinton said she would announce a plan to stop "price gouging" for specialty drugs.
Biogen fell 5.6 percent to $297.16 and Gilead was down 2.5 percent at $105.74.
The S&P healthcare sector fell 1.4 percent and was the only S&P 500 sector index to end lower. The Nasdaq biotech index slumped 4.4 percent.
Financial shares bounced back after losing ground following Thursday's Federal Reserve decision to keep rates unchanged. The S&P financial index was up 1.1 percent. Continuación...